Monoamine oxidase inhibitors (MAOIs) were the first medications approved for the treatment of depression symptoms and are also used to treat several other medical conditions, such as Parkinson's ...

Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B ... selective and irreversible inhibitor of MAO-B that has ...

Am J Health Syst Pharm. 2006;63(10):915-928. Results of this study suggest that adjunctive rasagiline significantly reduces off time with efficacy similar to that observed by adding entacapone to ...

rich in monoamine oxidase inhibitors that prevent DMT's breakdown in the digestive system. The resulting synergy produces an intense, often transformative experience by enhancing serotonergic ...

If currently taking a prescription monoamine oxidase inhibitor (MAOI) (eg, certain drugs taken for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after ...

Medically reviewed by Suzanne Fisher, RD If you’re one of the 85% of American adults who drink alcohol, whether occasionally ...

Bupropion is a relatively weak inhibitor of the neuronal uptake of norepinephrine and dopamine and does not inhibit monoamine oxidase or the reuptake of serotonin. Swallow whole. Avoid bedtime dosing.